These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

718 related articles for article (PubMed ID: 29202655)

  • 21. Ketamine metabolite pilot study in a suicidal depression trial.
    Grunebaum MF; Galfalvy HC; Choo TH; Parris MS; Burke AK; Suckow RF; Cooper TB; Mann JJ
    J Psychiatr Res; 2019 Oct; 117():129-134. PubMed ID: 31415914
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ketamine for rapid reduction of suicidal ideation: a randomized controlled trial.
    Murrough JW; Soleimani L; DeWilde KE; Collins KA; Lapidus KA; Iacoviello BM; Lener M; Kautz M; Kim J; Stern JB; Price RB; Perez AM; Brallier JW; Rodriguez GJ; Goodman WK; Iosifescu DV; Charney DS
    Psychol Med; 2015 Dec; 45(16):3571-80. PubMed ID: 26266877
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Repeat-dose ketamine augmentation for treatment-resistant depression with chronic suicidal ideation: A randomized, double blind, placebo controlled trial.
    Ionescu DF; Bentley KH; Eikermann M; Taylor N; Akeju O; Swee MB; Pavone KJ; Petrie SR; Dording C; Mischoulon D; Alpert JE; Brown EN; Baer L; Nock MK; Fava M; Cusin C
    J Affect Disord; 2019 Jan; 243():516-524. PubMed ID: 30286416
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rapid and sustained antidepressant effects of intravenous ketamine in treatment-resistant major depressive disorder and suicidal ideation: a randomized clinical trial.
    Zolghadriha A; Anjomshoaa A; Jamshidi MR; Taherkhani F
    BMC Psychiatry; 2024 May; 24(1):341. PubMed ID: 38714931
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ketamine rapidly relieves acute suicidal ideation in cancer patients: a randomized controlled clinical trial.
    Fan W; Yang H; Sun Y; Zhang J; Li G; Zheng Y; Liu Y
    Oncotarget; 2017 Jan; 8(2):2356-2360. PubMed ID: 27926528
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Esketamine Nasal Spray for Rapid Reduction of Major Depressive Disorder Symptoms in Patients Who Have Active Suicidal Ideation With Intent: Double-Blind, Randomized Study (ASPIRE I).
    Fu DJ; Ionescu DF; Li X; Lane R; Lim P; Sanacora G; Hough D; Manji H; Drevets WC; Canuso CM
    J Clin Psychiatry; 2020 May; 81(3):. PubMed ID: 32412700
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ketamine for acute suicidal ideation. An emergency department intervention: A randomized, double-blind, placebo-controlled, proof-of-concept trial.
    Domany Y; Shelton RC; McCullumsmith CB
    Depress Anxiety; 2020 Mar; 37(3):224-233. PubMed ID: 31733088
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterizing the course of suicidal ideation response to ketamine.
    Ballard ED; Yarrington JS; Farmer CA; Richards E; Machado-Vieira R; Kadriu B; Niciu MJ; Yuan P; Park L; Zarate CA
    J Affect Disord; 2018 Dec; 241():86-93. PubMed ID: 30099268
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Study protocol for Ketamine as an adjunctive therapy for major depression (2): a randomised controlled trial (KARMA-Dep [2]).
    Jelovac A; McCaffrey C; Terao M; Shanahan E; Mohamed E; Whooley E; McDonagh K; McDonogh S; Igoe A; Loughran O; Shackleton E; O'Neill C; McLoughlin DM
    BMC Psychiatry; 2023 Nov; 23(1):850. PubMed ID: 37974160
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improvement in suicidal ideation after ketamine infusion: relationship to reductions in depression and anxiety.
    Ballard ED; Ionescu DF; Vande Voort JL; Niciu MJ; Richards EM; Luckenbaugh DA; Brutsché NE; Ameli R; Furey ML; Zarate CA
    J Psychiatr Res; 2014 Nov; 58():161-6. PubMed ID: 25169854
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antisuicidal Response Following Ketamine Infusion Is Associated With Decreased Nighttime Wakefulness in Major Depressive Disorder and Bipolar Disorder.
    Vande Voort JL; Ballard ED; Luckenbaugh DA; Bernert RA; Richards EM; Niciu MJ; Park LT; Machado-Vieira R; Duncan WC; Zarate CA
    J Clin Psychiatry; 2017; 78(8):1068-1074. PubMed ID: 27929610
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Replication of ketamine's antidepressant efficacy in bipolar depression: a randomized controlled add-on trial.
    Zarate CA; Brutsche NE; Ibrahim L; Franco-Chaves J; Diazgranados N; Cravchik A; Selter J; Marquardt CA; Liberty V; Luckenbaugh DA
    Biol Psychiatry; 2012 Jun; 71(11):939-46. PubMed ID: 22297150
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of anhedonia and suicidal ideation in patients with treatment-refractory depression after intravenous ketamine infusions.
    Zheng W; Gu LM; Yang XH; Zhou YL; Wang CY; Lan XF; Zhang B; Ning YP
    Int J Psychiatry Clin Pract; 2023 Jun; 27(2):145-150. PubMed ID: 36309806
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ketamine as augmentation for the treatment of major depression and suicidal risk in advanced cancer: Case report.
    Rodríguez-Mayoral O; Pérez-Esparza R; Domínguez-Ocadio G; Allende-Pérez S
    Palliat Support Care; 2020 Feb; 18(1):110-112. PubMed ID: 31397251
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and Safety of Intranasal Esketamine for the Rapid Reduction of Symptoms of Depression and Suicidality in Patients at Imminent Risk for Suicide: Results of a Double-Blind, Randomized, Placebo-Controlled Study.
    Canuso CM; Singh JB; Fedgchin M; Alphs L; Lane R; Lim P; Pinter C; Hough D; Sanacora G; Manji H; Drevets WC
    Am J Psychiatry; 2018 Jul; 175(7):620-630. PubMed ID: 29656663
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Psychedelic Therapy: A Primer for Primary Care Clinicians-Ketamine.
    Evans VD; Arenas A; Shinozuka K; Tabaac BJ; Beutler BD; Cherian K; Fasano C; Muir OS
    Am J Ther; 2024 Mar-Apr 01; 31(2):e155-e177. PubMed ID: 38518272
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Subanesthetic ketamine infusions for suicide ideation in patients with bipolar and unipolar treatment refractory depression.
    Kang MJY; Kulcar E; Chandrasena R; Anjum MR; Fairbairn J; Hawken ER; Vazquez GH
    Psychiatry Res; 2021 Feb; 296():113645. PubMed ID: 33360430
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of melancholic features on positive and negative suicidal ideation in patients with treatment-resistant depression and strong suicidal ideation receiving low-dose ketamine infusion.
    Chen MH; Su TP; Li CT; Lin WC; Wu HJ; Tsai SJ; Bai YM; Mao WC; Tu PC
    Eur Arch Psychiatry Clin Neurosci; 2024 Jun; 274(4):759-766. PubMed ID: 38052767
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Single and repeated ketamine infusions for reduction of suicidal ideation in treatment-resistant depression.
    Phillips JL; Norris S; Talbot J; Hatchard T; Ortiz A; Birmingham M; Owoeye O; Batten LA; Blier P
    Neuropsychopharmacology; 2020 Mar; 45(4):606-612. PubMed ID: 31759333
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Subcutaneous ketamine reduces suicide risk and improves functioning in depression: A proof-of-concept study.
    Anzolin AP; Baldez DP; Montezano BB; Kapczinski F; de Abreu PB; Kauer-Sant'Anna M
    Psychiatry Res; 2024 Jul; 337():115915. PubMed ID: 38688118
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.